Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 11 of 1714:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type III, alpha SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View
sodium channel, voltage-gated, type II, beta SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View
sodium channel, voltage-gated, type II, alpha 2 SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View
sodium channel, voltage-gated, type I, beta SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View
sodium channel, voltage-gated, type I, alpha SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View
sodium channel, voltage-gated, type IV, beta BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel associated protein 1 BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel associated protein 2 BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type III, beta BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type I, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type IX, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type VII, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
amiloride-sensitive cation channel 5, intestinal BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type III, beta BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type XI, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type I, beta BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type 10, alpha polypeptide BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type IV, alpha polypeptide BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type V, alpha polypeptide BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type II, beta BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, nonvoltage-gated 1 alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, nonvoltage-gated 1 gamma BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, nonvoltage-gated 1 beta BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type XI, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, nonvoltage-gated 1, gamma BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, nonvoltage-gated 1, delta BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, nonvoltage-gated 1 alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type X, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type IX, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage gated, type VIII, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type V, alpha polypeptide RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type II, beta RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, nonvoltage-gated 1 alpha RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, nonvoltage-gated 1 gamma RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, nonvoltage-gated 1 beta RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type XI, alpha RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, nonvoltage-gated 1, gamma RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, nonvoltage-gated 1, delta RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, nonvoltage-gated 1 alpha RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type X, alpha RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type IX, alpha RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage gated, type VIII, alpha RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type VII, alpha RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type IV, beta RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type IV, alpha RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type III, alpha RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type II, beta RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type II, alpha 2 RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type I, beta RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type I, alpha RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
5-hydroxytryptamine (serotonin) receptor 2B OLANZAPINE Serotonin 5-HT2B 100% .057uM .036uM View
5-hydroxytryptamine receptor 6 OLANZAPINE Serotonin 5-HT6 100% .013uM .006109uM View
arachidonate 15-lipoxygenase, second type OLANZAPINE Lipoxygenase 15-LO 100% 2.768uM NoneNone View
arachidonate 15-lipoxygenase OLANZAPINE Lipoxygenase 15-LO 100% 2.768uM NoneNone View
arachidonate 15-lipoxygenase OLANZAPINE Lipoxygenase 15-LO 100% 2.768uM NoneNone View
adrenergic receptor, alpha 1b OLANZAPINE Adrenergic alpha1B 100% .037uM .021uM View
dopamine receptor D1A OLANZAPINE Dopamine D1 100% .072uM .036uM View
dopamine receptor D3 OLANZAPINE Dopamine D3 100% .078uM .027uM View
prostaglandin-endoperoxide synthase 2 NIFLUMIC ACID Cyclooxygenase COX-2 100% .918uM NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) NIFLUMIC ACID Cyclooxygenase COX-2 100% .918uM NoneNone View
adrenergic receptor, alpha 1b NORTRIPTYLINE Adrenergic alpha1B 100% .207uM .114uM View
adrenergic receptor, alpha 2b NORTRIPTYLINE Adrenergic alpha2B 100% .094uM .043uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 NORTRIPTYLINE Adrenergic, Norepinephrine Transporter 100% .00321uM .003184uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 NORTRIPTYLINE Serotonin Transporter 100% .013uM .006977uM View
progesterone receptor CYPROTERONE ACETATE Progesterone 100% .037uM .004842uM View
progesterone receptor CYPROTERONE ACETATE Progesterone 100% .037uM .004842uM View
androgen receptor NORGESTREL Testosterone 100% .006399uM .004266uM View
5-hydroxytryptamine (serotonin) receptor 2A NORTRIPTYLINE Serotonin 5-HT2A 100% .051uM .015uM View
histamine receptor H 1 NORTRIPTYLINE Histamine H1, Central 100% .05uM .005862uM View
mu-opioid receptor MOR NALBUPHINE Opiate mu 100% .024uM .009925uM View
progesterone receptor NORGESTREL Progesterone 100% .003509uM .000458uM View
progesterone receptor NORGESTREL Progesterone 100% .003509uM .000458uM View
dopamine receptor D3 NORTRIPTYLINE Dopamine D3 100% .179uM .061uM View
progesterone receptor NORETHINDRONE ACETATE Progesterone 100% .028uM .003615uM View
progesterone receptor NORETHINDRONE ACETATE Progesterone 100% .028uM .003615uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid A receptor, gamma 1 NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid A receptor, pi NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
AT hook, DNA binding motif, containing 1 (DBSS) NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid A receptor, theta NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid A receptor, gamma 2 NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid A receptor, alpha 2 NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid A receptor, alpha 1 NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid A receptor, delta NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 NIMETAZEPAM GABAA, Benzodiazepine, Central 100% .104uM .085uM View
opioid receptor, kappa 1 NALBUPHINE Opiate kappa 100% .111uM .044uM View
sodium channel, voltage-gated, type IV, beta SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View
sodium channel associated protein 1 OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel associated protein 2 OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type III, beta OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type I, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type IX, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type VII, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
amiloride-sensitive cation channel 5, intestinal OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type I, beta RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type 10, alpha polypeptide RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel, voltage-gated, type IV, alpha polypeptide RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
calcium channel, voltage-dependent, gamma subunit 4 EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, gamma subunit 3 EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, gamma subunit 2 EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, gamma subunit 1 EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, beta 4 subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, beta 3 subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, beta 2 subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, alpha 1F subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, beta 1 subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 EBASTINE Calcium Channel Type L, Phenylalkylamine 100% .1185uM .1152uM View
dopamine receptor D3 EBASTINE Dopamine D3 100% .1216uM .0413uM View
histamine receptor H 1 EBASTINE Histamine H1, Central 100% .0283uM .003287uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 OXYBUTYNIN Dopamine Transporter 100% .0855uM .0679uM View
cholinergic receptor, muscarinic 1 OXYBUTYNIN Muscarinic M1 100% .003518uM .000847uM View
cholinergic receptor, muscarinic 4 OXYBUTYNIN Muscarinic M4 100% .001994uM .000278uM View
sodium channel, voltage-gated, type IV, beta OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel associated protein 1 OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel associated protein 2 OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type III, beta OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type I, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type IX, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type VII, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
amiloride-sensitive cation channel 5, intestinal OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type III, beta OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type XI, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type I, beta OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type 10, alpha polypeptide OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type IV, alpha polypeptide OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type V, alpha polypeptide OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type II, beta OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, nonvoltage-gated 1 alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, nonvoltage-gated 1 gamma OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, nonvoltage-gated 1 beta OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type XI, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, nonvoltage-gated 1, gamma OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, nonvoltage-gated 1, delta OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, nonvoltage-gated 1 alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type X, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type III, beta OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type XI, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type I, beta OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type 10, alpha polypeptide OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type IV, alpha polypeptide OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type V, alpha polypeptide OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type II, beta OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, nonvoltage-gated 1 alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, nonvoltage-gated 1 gamma OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, nonvoltage-gated 1 beta OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type XI, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, nonvoltage-gated 1, gamma OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, nonvoltage-gated 1, delta OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, nonvoltage-gated 1 alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type X, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type IX, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage gated, type VIII, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type VII, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type IV, beta OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type IV, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type III, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type II, beta OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type II, alpha 2 OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type I, beta OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
sodium channel, voltage-gated, type I, alpha OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
adrenergic receptor, alpha 2b OXICONAZOLE Adrenergic alpha2B 100% 3.6499uM 1.6663uM View
cholinergic receptor, muscarinic 3 OXYBUTYNIN Muscarinic M3 100% .00271uM .000574uM View
cholinergic receptor, muscarinic 2 OXYBUTYNIN Muscarinic M2 100% .027uM .009612uM View
cholinergic receptor, muscarinic 5 OXYBUTYNIN Muscarinic M5 100% .003222uM .002315uM View
5-hydroxytryptamine (serotonin) receptor 1A OXYMETAZOLINE Serotonin 5-HT1A 100% .005613uM .003208uM View
progesterone receptor NORETHINDRONE Progesterone 100% .009342uM .001218uM View
progesterone receptor NORETHINDRONE Progesterone 100% .009342uM .001218uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 OXICONAZOLE Serotonin Transporter 100% .8001uM .4251uM View
A3 adenosine receptor OXICONAZOLE Adenosine A3 100% .6345uM .3586uM View
prostaglandin-endoperoxide synthase 1 NAPROXEN Cyclooxygenase COX-1 100% .211uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) NAPROXEN Cyclooxygenase COX-1 100% .211uM NoneNone View
androgen receptor NORETHINDRONE Testosterone 100% .022uM .015uM View
tachykinin receptor 2 RITONAVIR Tachykinin NK2 100% 2.622uM .874uM View
5-hydroxytryptamine (serotonin) receptor 2C NORTRIPTYLINE Serotonin 5-HT2C 100% .016uM .008169uM View
sodium channel, voltage-gated, type IV, beta RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel associated protein 1 RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View
sodium channel associated protein 2 RESERPINE Sodium Channel, Site 2 100% .774uM .706uM View